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Protective vaccination induces self-healing of otherwise fatal blood-stage malaria of
Plasmodium chabaudi in female Balb/c mice. To trace processes critically involved in
self-healing, the liver, an effector against blood-stage malaria, is analyzed for possible
changes of its transcriptome in vaccination-protected in comparison to non-protected
mice toward the end of the crisis phase. Gene expression microarray analyses
reveal that vaccination does not affect constitutive expression of mRNA and lincRNA.
However, malaria induces significant (p < 0.01) differences in hepatic gene and
lincRNA expression in vaccination-protected vs. non-vaccinated mice toward the end
of crisis phase. In vaccination-protected mice, infections induce up-regulations of
276 genes and 40 lincRNAs and down-regulations of 200 genes and 43 lincRNAs,
respectively, by >3-fold as compared to the corresponding constitutive expressions.
Massive up-regulations, partly by >100-fold, are found for genes as RhD, Add2,
Ank1, Ermap, and Slc4a, which encode proteins of erythrocytic surface membranes,
and as Gata1 and Gfi1b, which encode transcription factors involved in erythrocytic
development. Also, Cldn13 previously predicted to be expressed on erythroblast
surfaces is up-regulated by >200-fold, though claudins are known as main constituents
of tight junctions acting as paracellular barriers between epithelial cells. Other genes
are up-regulated by <100- and >10-fold, which can be subgrouped in genes encoding
proteins known to be involved in mitosis, in cell cycle regulation, and in DNA repair.
Our data suggest that protective vaccination enables the liver to respond to P. chabaudi
infections with accelerated regeneration and extramedullary erythropoiesis during crisis,
which contributes to survival of otherwise lethal blood-stage malaria.
Keywords: blood-stagemalaria, Plasmodium chabaudi, protective vaccination, gene expression, lincRNA, hepatic
erythropoiesis, liver regeneration
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INTRODUCTION
Malaria has caused worldwide about 214 million new cases and
about 438,000 deaths in 2015 (WHO, 2015). The liver plays an
important role in malaria. It is the organ of intra-hepatocyte
multiplication of the pre-erythrocytic stages of the malaria-
causing agent, parasitic protozoans of the genus Plasmodium
(Bertolino and Bowen, 2015; Frevert and Krzych, 2015; Frevert
et al., 2015). Moreover, the liver responds to the morbidity-
and mortality-causing blood-stages of the parasites. The liver is
pathologically changed and even massively injured in patients
suffering from blood-stage malaria (Ananad et al., 1992; Kochar
et al., 2003; Nautyal et al., 2005; Rupani and Amarapurkar, 2009).
Also, the liver with its inherent immune system even functions as
an effector against blood-stage malaria (Dockrell et al., 1980; Abo
and Sekikawa, 2002; Wunderlich et al., 2005, 2014). The latter
view is supported by studies performed with animal models, as
e.g., Plasmodium chabaudi in mice. This model shares several
characteristics with P. falciparum, the most dangerous malaria
species for humans (Longley et al., 2011; Stephens et al., 2012).
Mice are either susceptible or resistant to P. chabaudi malaria,
i.e., blood-stage infections take either a lethal or a self-healing
outcome. This outcome is under complex control involving genes
of the mouse-MHC, the H-2 complex, and genes of the non-H-2
background as well as environmental factors (Wunderlich et al.,
1988b, 2014). Both lethal and self-healing infections take a similar
course of peripheral parasitemia during the pre-crisis phase. For
instance, whenmice are challenged with 106 P. chabaudi-infected
erythrocytes, precrisis culminates at peak parasitemia of about
40–50% on approximately day 8 p.i. The following crisis phase,
characterized by dramatically declining peripheral parasitemia to
about 2–1% within about 3–4 days, is apparently critical for the
outcome of disease. Indeed, all susceptible mice succumb during
crisis, whereas resistant mice will survive and generate long-
lasting immune mechanisms against homologous re-challenge
(Wunderlich and Helwig, 1987).
An effective anti-malaria vaccine for humans is currently not
yet available. However, there are promising candidate vaccines
in progress (Halbroth and Draper, 2015; Hoffman et al., 2015;
Miura, 2016). To date, only RTS,S/AS01 vaccine has completed
a phase 3 evaluation (White et al., 2015). Although RTS,S/AS01
received a positive regulatory assessment by the European
Medicine Agency for its active immunization of children aged
6 weeks to 17 months against malaria it was not recommended
by the WHO (Birkett, 2016; Gosling and von Seidlein, 2016).
Moreover, the protective mechanisms of the host defense,
which have to be activated by a vaccine, appear to be not yet
fully understood despite enormous advances in our knowledge
during the past 35 years. At least, however, those protective
mechanisms directed against blood-stage malaria can be also
conveniently investigated in the P. chabaudi model. Indeed,
there has been previously developed a vaccination procedure
which raises survival of malaria-susceptible mice from 0 to
over 80% (Wunderlich et al., 1988a; Krücken et al., 2009). This
vaccination, using non-infectious surface membranes isolated
from P. chabaudi-infected erythrocytes, does not induce sterile
immunity, but converts lethal blood-stage infections to take a
self-healing course. Moreover, there is information available,
though still little, that protective vaccination also affects the liver
(Krücken et al., 2009; Wunderlich et al., 2014). This becomes
evident especially during the crisis phase, when vaccination leads
to a dramatic increase in the hepatic capacity to trap injected
particles (Krücken et al., 2009).
The processes associated with protective vaccination in the
liver during crisis are only poorly investigated to date. To trace
these processes, it would be initially meaningful to identify those
genes whose expression is changed in the liver of vaccination-
induced self-healing infections toward the end of the crisis phase.
This would in turn allow deductions for processes possibly
involved in the liver to mediate protection against blood-stage
malaria. We have therefore decided to analyze the effect of
protective vaccination on the transcriptome of the liver toward
the end of the crisis phase in vaccination-induced self-healing
infections of P. chabaudi in comparison to lethal infections




This study continues our previous work performed with female
Balb/c mice (Krücken et al., 2009). It was carried out in
strict accordance with the German law on animal protection.
The keeping of mice as well as the experimental protocol
of the study were officially approved by the State-controlled
Committee on the Ethics of Animal Experiments of the State
Nordrhein-Westfalen, Germany, and were regularly controlled,
without being previously announced, by the local authorities.
All efforts were made to minimize suffering. Female Balb/c
mice were delivered at an age of 10–12 weeks from our central
animal facilities at the University of Düsseldorf, where they
were bred under specified pathogen-free conditions. During the
experiments, the mice were housed in plastic cages, received a
standard diet (Woehrlin, Bad Salzuflen, Germany) and water ad
libitum.
Blood-Stage Malaria
Blood-stage infections of P. chabaudi were routinely maintained
in outbred mice under sterile conditions by weekly passages of
infected blood. Since 1982, a non-clonal line of P. chabaudi is
continuously used in our laboratory (Wunderlich et al., 1982)
resembling to P. chabaudi as described previously (Wunderlich
et al., 2005; Krücken et al., 2009). Balb/c mice were challenged
i.p. with 106 P. chabaudi chabaudi AS-infected erythrocytes.
Parasitemia was evaluated in Giemsa-stained smears from tail
blood. Erythrocytes were counted in a Neubauer chamber.
Protective Vaccination
Mice were vaccinated as detailed previously (Krücken et al.,
2009). The vaccine contained host cell plasma membranes
isolated in the form of ghosts from P. chabaudi-parasitized red
blood cells as detailed previously (Wunderlich et al., 1985, 1987).
These membranes were previously characterized to be non-
infectious and to be associated with parasite-synthesized proteins
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(Wunderlich et al., 1988c,d) as it was also reported for surface
membranes of P. falciparum-infected erythrocytes (Fontaine
et al., 2012). Approximately 106 ghosts were suspended in 100 µl
Freund’s complete adjuvant (FCA) and subcutaneously injected
3 and 1 week before infecting with P. chabaudi-parasitized
erythrocytes. Controls received only FCA.
RNA Isolation
Livers were aseptically removed from sacrificed mice, rapidly
frozen in liquid nitrogen and stored at −80◦C until use. Frozen
livers were grounded in a mortar under liquid nirogen and
aliquots of each liver were used to isolate total RNA by the
Trizol (Qiagen, Hilden, Germany) standard RNA extraction
protocol. Trizol-extracted RNAwas additionally cleaned up using
the miRNeasy Kit (Qiagen). Integrity and quality of RNA was
checked with the Agilent 2100 Bioanalyzer platform (Agilent
Technologies). All RNA samples revealed RIN values between 8.7
and 9.1.
Cy3-Labeling of RNA
Equivalents of 100 ng from each RNA sample were used
for the linear T7-based amplification step. To produce Cy3-
labeled cRNA, the RNA samples were amplified and labeled
with the Agilent Low Input Quick Amp Labeling Kit (Agilent
Technologies) according to the manufacturer’s instructions.
Yields of cRNA and dye-incorporation were determined with
the ND-1000 Spectrophotometer (NanoDrop Technologies). The
incorporations were between 18 and 23 fmol Cy3/ng cRNA.
Hybridization of Agilent Mouse Whole
Genome Oligo Microarrays
Hybridization was performed with Agilent’s 8 × 60K oligo
microarrays (design 028005), which contain 8 arrays per slide
with each array displaying 39,430 Entrez Gene RNAs and 16,251
lincRNAs. Using the Agilent Gene Expression Hybridization
Kit, hybridization was carried out as detailed in the Agilent
processing protocol (Agilent technologies). In brief, 600 ng
Cy3-labeled fragmented cRNA in hybridization buffer was
hybridized overnight at 65◦C to the microarrays using Agilent’s
recommended hybridization chamber and oven. Finally, the
microarrays were washed with the Agilent Gene Expression
Wash Buffer 1 for 1min at room temperature, which was
followed by washing with preheated Agilent Gene Expression
Wash Buffer 2 at 37◦C for 1min.
Scanning and Data Analysis
The Agilent’s Microarray Scanner System (Agilent Technologies)
was used to detect fluorescence signals on the hybridized
microarrays. The microarray image files were read out and
processed with the Agilent Feature Extraction Software. The
latter determines feature intensities (including background
substraction), rejects outliers and calculates statistical
confidences. A heatmap was generated to visualize the expression
levels of each mRNA and lincRNA (Spotfire, TIBCO Software
Inc., Palo Alto, USA). The row and column dendrograms
were clustered with the unweighted pair group method with
arithmetic mean and Euclidean distance measure. Data are
publicly available at the EMBL-EBI Array Express repository
(Array Express accession number: E-MTAB-4791).
Quantitative Real-Time PCR
Using High Capacity cDNA Reverse Transcription Kit (Life
Technologies) and TaqMan mRNA assays (Life Technologies)
we performed reverse transcription of mRNAs coding for
the following proteins: RHD (assay ID: Mm00456910_m1),
ERMAP (Mm_00469273_m1), ADD2 (Mm00478923_m1),
ANK1 (Mm00482889_m1), PLK1 (Mm00440924_g1), CCNA2
(Mm00438063_m1), LIFR (Mm00442942_m1), and CD163
(Mm_00474091_m1). PCR reactions were performed with the
TaqMan R© gene expression master mix (Life Technologies)
according manufacturer’s protocol on a 7900HT real-time PCR
System, as described previously (Al-Quraishy et al., 2014).
All samples were run in duplicates and raw ct values were
calculated using the SDS software v.2.4 and GAPDH was used
for normalization. Fold change of expression was calculated with
the comparative Ct method (2−11ct) (Livak and Schmittgen,
2002). Data sets were analyzed for statistical significance using
two-tailed unpaired heteroskedastic Student’s t-test (∗p< 0.01).
RESULTS
Identification of Differentially Expressed
Genes in the Liver of
Vaccination-Protected vs. Non-protected
Mice
To identify differentially expressed genes in the liver of
vaccination-protected mice, in comparison with non-vaccinated
malaria-susceptible mice, toward the end of the crisis phase of
blood-stage infections of P. chabaudi, we have analyzed gene
expression microarrays from livers individually prepared from
three vaccination-protected mice on day 11 p.i. (Vd11) and from
3 vaccinated mice before infection on day 0 p.i. (Vd0) as well as
from 3 non-vaccinated mice on day 0 p.i. (Nd0) and on day 11
p.i. (Nd11). The course of parasitemias of P. chabaudi infections
in vaccinated and non-vaccinated mice has been previously
determined under identical experimental conditions as used here
(Krücken et al., 2009). The parasitemia was 0% at Vd0 and Nd0
and approximately 2% at Vd11 and Nd11, respectively. Then, we
have stringently selected for those genes, which displayed more
than 3-fold changed mRNA expression levels at a significance
level of p< 0.01 at Vd11 and Nd11 relative to the corresponding
constitutive mRNA expressions at Vd0 and Nd0, respectively.
Figure 1 shows the heat maps of the expression profiles of all
self-healing and lethal infections on day 0 p.i. and day 11 p.i. The
profiles of Vd0 and Nd0 separately cluster from those of Vd11
and Nd11, respectively.
Protective vaccination does not affect constitutive mRNA
expression in the liver. However, the P. chabaudi infections
induce significant changes in the expression of numerous hepatic
genes, which differ between vaccination-protected and non-
vaccinated Balb/c mice toward the end of the crisis phase of
blood-stage infections of P. chabaudi on day 11 p.i. The Venn
diagrams in Figure 2 summarize the number of identified genes:
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FIGURE 1 | Heatmap of global expression levels of mRNA and lincRNA in the liver of non-vaccinated (N) and vaccinated (V) mice on day 0 p.i. (Nd0,
Vd0) and day 11 p.i. (Nd11, Vd11). Expression levels for each sample were hierarchically clustered. Log2 transformed expression levels range from −4 to 12
indicated by blue and red color, respectively.
malaria induces 302 genes to be up- and 1,147 genes to be
down-regulated by more than 3-fold at Nd11 in relation to their
constitutive expressions at Nd0. The identity of these genes is
provided in the Tables S1–S4. Tables S1, S2 list the genes whose
expression is up- and down-regulated by more than 3-fold and
less than 10-fold, respectively. In Tables S3, S4, those genes
are summarized whose expression is more than 3-fold up and
less than 10-fold down-regulated, respectively, in the liver of
non-vaccinated mice.
Moreover, Figure 2 shows 48 and 369 genes exhibiting
malaria-induced up- and down-regulated expressions,
respectively, by more than 3-fold both at Nd11 and at
Vd11 as compared with their constitutive expressions at
Nd0 and Vd0. The Tables S5, S6 summarize those genes, whose
expression is up- and down-regulated, respectively, by more
than 3-fold and less than 10-fold in the liver of both vaccinated
and non-vaccinated mice. Table 1 lists those 4 genes and 14
genes, respectively, whose expressions are significantly up- and
down-regulated by more than 10-fold in both non-vaccinated
susceptible mice and vaccination-protected mice (Figure 2).
However, the differences between both groups are not larger than
about 2-fold—if at all. The 4 up-regulated genes are Apol10b,
Hbq1b, Fcho1, and D1gap5. Among the 14 down-regulated
genes, there are Cd209b and the 3 Mups2, 17, and 19, which are
known to encode pheromone-binding proteins. Other genes
encode proteins which are involved in liver metabolism and
these genes are down-regulated to about the same extent in
vaccination-protected and non-vaccinated mice.
Protective vaccination does not only induce self-healing
infections of P. chabaudi, but also the number and identity
of the malaria-induced genes in the liver at Vd11 differ from
those identified in non-vaccinated mice at Nd11: 276 and
200 genes have been identified to be up- and down-regulated,
respectively, more than 3-fold at Vd11 in relation to Vd0
(Figures 2A,B). Tables S7, S8 list the 43 and 112 genes genes
whose expression levels are significantly (p < 0.01) up- and
down-regulated between 3- and 10-fold at Vd11 in relation to
Vd0 (Figures 2A,B). In the following, the focus of this study will
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FIGURE 2 | Venn-diagram of the number of up-regulated (A) and
down-regulated (B) genes expressed more than 3-fold (p < 0.01) in the
liver of vaccinated mice infected with P. chabaudi toward the end of
the crisis phase on day 11 p.i. (Vd11) in comparison to constitutive
expressions day 0 p.i. (Vd0). Nd11 vs. Nd0 indicates number of those
genes identified in the liver of non-vaccinated mice. Numbers in brackets
indicate genes more than 10-fold changed.
be on those genes which are more than 10-fold (p < 0.01) up- or
down-regulated by malaria in the liver of vaccination-protected
mice at Vd11.
Characterization of Genes Up-Regulated in
Vaccination-Protected Mice
Among the 276 genes with up-regulated expression in the liver
of only vaccination-protected mice toward the end of the crisis
phase on day 11 p.i., there are 60 genes, whose expression
is more than 10-fold up-regulated at Vd11 in comparison to
Vd0, respectively (Figure 2A). These 60 genes are listed in
Table 2, which also provides information about the currently
annotated functions of their encoded proteins. The 60 up-
regulated genes can be subsumed under specific functional
groups. The most prominent group contains genes, which can
be even up-regulated by far more than 100-fold, and which
code for different erythroid-associated proteins, in particular
proteins associated with the surface membrane. For instance, the
Rhd encodes the RhD blood group, Add 2, Ank1, and Tmod1
encode proteins associated with membrane skeletal proteins,
Ermap encodes a cell adhesion mediator, and Slc4a1 an integral
membrane protein. Besides these membrane-associated genes,
this group of genes also containsGata1 andGfi1bwhich are more
than 70-fold up-regulated and which encode transcription factors
involved in the development of erythroid cells. Another major
group comprises genes which are associated with different phases
of mitotis, such as Aspm, Bub1b, Casc5, Ccna2, Cdca5, Cenpe,
Diap3, Ercc6l, Hist1h2ab, Hist3h2ba, Kif4, Kif15, Kif18b, Mns1,
Nusap1, Prc1, Sgol1, Ska1, Spag5, Ube2c, and Uhrf1. Another
group summarizes genes coding for proteins involved in cell
cycle regulation, as e.g., Birc5, Bub1, Ccnb1, Ccnb2, Cdc25b, Espl1,
Melk, Mybl2, Plk1, Rgcc, and Rrm2. The four genes Bard1, Fanci,
Neil3, and Top2a code for proteins which have been described
to be involved in DNA repair mechanisms. Moreover, the genes
Kcnn4a and Mki67encode proteins involved in signaling and
cell proliferation. Furthermore, the genes Cd24a, Lrr1, Pbk,
and Trim59 can be assigned to immunity. Two genes can be
subgrouped to tissue permeability, among which is Cldn13 that
is more than 200-fold up-regulated. The encoded membrane
protein claudin13 is known to be associated with tight junctions.
Finally, quantitative PCR of arbitrarily selected up-regulated
genes confirms that the expression of the erythroid-associated
genes Add2, Ank1, Ermap, and Rhd are indeed up-regulated
by more than 100-fold, while the genes Ccna2 associated with
mitosis and Plk1 involved in cell cycle regulation are more than
10-fold expressed in the liver of vaccination-protected Balb/c
mice infected with P. chabaudi on day 11 p.i. (Vd11) in relation




Among the 200 genes down-regulated in the liver of vaccination-
protected mice at Vd11, only 5 genes in the liver respond to
malaria with a significant down-regulation by more than 10-
fold (p < 0.01) (Figure 2B). One of these 5 genes is Cd163
which is down-regulated by approximately 50-fold (Table 3).
The encoded CD163 is a transmembrane protein of 130
KDa expressed on Kupffer cells in the liver serving as a
scavenger receptor cysteine-rich superfamily in the clearence and
endocytosis of hemoglobin/haptoglobin complexes (Gronbaek
et al., 2012; Etzerodt et al., 2013). Another gene is Lifr, whose
expression is down-regulated by approximately 17-fold, encodes
the transmembrane leukemia inhibitory factor (LIF) receptor
(LIFR). Ectodomain shedding creates soluble receptor forms of
both LIFR and CD163, which have different functions as the
membrane-bound receptors (Layton et al., 1994; Owczarek et al.,
1996; Moller, 2012; Ingels et al., 2013; Onishi and Zandstra,
2015). Quantitative PCR confirms that the expression of both Lifr
and Cd163 is strongly down-regulated at Vd11 as compared with
Vd0 (Figure 3).
Identification of Differentially Expressed
lincRNAs
Besides the 39,430 Entrez Gene RNAs, the used microarrays
also contain 16,251 probes for detecting lincRNAs. In general,
lincRNAs are known to range in length between 200 nts and
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about 100 kb, but lincRNAs are never transcribed into proteins.
However, they are increasingly recognized as to play critical roles
in different diseases, including diverse liver diseases (Takashi
et al., 2014). We therefore also screened the microarrays for
lincRNAs using the same stringent conditions as above for the
mRNAs. Protective vaccinaton does not change the constitutive
expression of lincRNA. However, malaria has induced changes
in the expression of lincRNAs toward the end of the crisis
phase, which differ between vaccination-protected mice and
non-protected mice. The Venn-diagrams in Figure 4 show that,
vaccination-protected mice, malaria induces 40 lincRNAs to be
up-regulated more than 3-fold (Table S9), among which are 6
lincRNAs up-regulated by more than 10-fold at Vd11 in relation
to Vd0. About the same number, namely 43 lincRNAs, are down-
regulated by more than 3-fold in non-vaccinated mice at Vd11,
but none of them is more than 10-fold down-regulated (Table
S10). However, annotated functions are not yet available for any
of the differentially regulated lincRNAs.
DISCUSSION
The vaccination procedure used here has been previously shown
to protect female Balb/c mice from fatal P. chabaudi blood-stage
malaria (Krücken et al., 2009). This becomes evident toward
the end of the crisis phase on day 11 p.i., when all non-
vaccinated mice will succumb to infections, but the majority of
the vaccinated mice will survive. This survival is associated with
malaria-induced differential expression of genes and lincRNAs
in the liver, as identified in the present study. These changes in
gene expression are presumably associated with processes in the
liver, which contribute to survival of blood-stage malaria of P.
chabaudi.
Extramedullary erythropoiesis obviously is one of these
malaria-activated processes in the liver of vaccination-protected
mice. Indeed, we have detected a massive up-regulation of
hepatic genes by far more than 100-fold, which encode diverse
proteins of erythroid cells. In accordance, previous findings have
provided evidence for the onset of hepatic erythropoiesis during
blood-stage malaria in mice (Abo and Sekikawa, 2002; Halder
et al., 2003; Wunderlich et al., 2014). It is therefore rather
likely that reticulocytes produced in the liver contribute to the
increasing number of peripheral reticulocytes in vaccination-
induced self-healing infections of P. chabaudi. This increase
begins at approximately peak parasitemia on day 8 p.i. and
reaches its maximum of approximately 80% at the end of
the crisis phase on approximately days 11 p.i., when the
number of peripheral erythrocytes has concomitantly declined
to a minimum (Krücken et al., 2009). This dramatic decline
of erythrocytes is presumably achieved both by mechanical
destruction of P. chabaudi-infected erythrocytes, when the
merozoite stages are released from erythrocytes, and by
erythrophagocytosis mediated through natural auto-antibodies
directed, for example, against clustered band 3 membrane
proteins of senescent and aberrant erythrocytes including even
P. falciparum-infected erythrocytes (Arese et al., 2005; Winograd
et al., 2005; Lutz, 2012; Lutz and Bogdanova, 2013). In this
Frontiers in Microbiology | www.frontiersin.org 13 July 2016 | Volume 7 | Article 1087
Al-Quraishy et al. Vaccination Augments Malaria-Induced Hepatic Erythropoiesis
FIGURE 3 | Quantitative PCR of mRNAs of arbitrarily selected up-regulated (A) and down-regulated (B) genes in the liver of vaccinated Balb/c mice
infected with P. chabaudi on day 0 p.i. (Vd0) and on day 11 p.i. (Vd11). Values are means of triplicate determinations. Bars indicate half SEM and stars significant
differences (p < 0.01) between Vd0 and Vd11.
context, it is worth mentioning that the spleen is rather likely
not that organ which massively removes P. chabaudi-infected
erythrocytes from circulation during the crisis phase of infection.
Indeed, the spleen during crisis dramatically decreases the uptake
of injected particulate material including fluorescently labeled
P. chabaudi-infected erythrocytes (Krücken et al., 2005, 2009),
while, concomitantly, the liver dramatically increases its capacity
to trap injected particles. Thus, the liver, for example the Kupffer
cells, rather than the “closed” spleen may massively remove
P. chabaudi-infected erythrocytes from circulation during crisis,
and this may even trigger hepatic erythropoiesis.
Anti-erythrocyte autoimmune mechanisms are obviously not
directed against reticulocytes, since their number is increasingly
replacing the declining number of erythrocytes during crisis.
Moreover, the massive increase in reticulocytes is—at least
transiently—advantageous for host survival, since reticulocytes,
in contrast to erythrocytes, are not the preferred host cells of
P. chabaudi. This non-preference may be due to the different
composition and arrangement of plasma membrane-associated
proteins of reticulocytes as compared with erythrocyte (Liu et al.,
2010), which would make it more difficult for P. chabaudi to
invade and/or survive in reticulocytes than in erythrocytes (Ott,
1968). This view is also supported by our finding showing
an massive up-regulation of genes encoding erythroid skeletal
membrane proteins such as Add2 and Ank1. In this context, it is
also noteworthy that C57BL/10 mice which have survived blood-
stagemalaria of P. chabaudi and subsequently acquired immunity
to homologous re-infection have been previously shown to
possess erythrocytes with a deficiency in the band 4.1a membrane
protein (Wunderlich andHelwig, 1987). Erythrocytes deficient in
4.1a are known to be prone to ovalocytosis (Alloisio et al., 1983)
and to be less penetrable by Plasmodium parasites (Hadley et al.,
1983).
Furthermore, we have identified quite a number of up-
regulated genes in the liver, which are known to control progress
of cell cycle, mitosis and DNA repair. This may be, at least
in part, also associated with increased hepatic erythropoiesis
including enucleation of erythroblasts which may be regarded
as an asymmetric form of mitosis (Thompson et al., 2010).
However, the most straightforward interpretation of these data
is that the liver of vaccination-protected mice, in comparison
with non-vaccinated mice, undergoes accelerated regeneration
toward the end of the crisis phase. This presumably enhances
recovery of the liver from the pathological damages and injuries
induced by the P. chabaudi infections. This view of accelerated
liver regeneration may be also supported by our finding that the
claudin13 encoding gene Cldn13 is one of the most massively
up-regulated genes in the liver of vaccination-protected mice
toward the end of the crisis phase. In the mouse genome,
Cldn13 is one of 26 genes encoding claudins, which are 4-pass
integral membrane proteins of 20–27 KDa and which are the
main constituents of tight junctions (Morita et al., 1999; Lal-
Nag and Morin, 2009). These restrict as a paracellular barrier
the uncontrolled transfer of water and solutes in the intercellular
space between cells of epithelia (Van Itallie and Anderson, 2004).
The massive upregulation of Cldn13may therefore contribute to
osmotic stability of liver tissue of the regenerating liver. However,
there is also information available that the mouse-specific Cldn13
encodes themost abundant claudin in the spleen of mice, where it
has been predicted to be localized on the surface of erythroblasts
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FIGURE 4 | Number of up-regulated (A) and down-regulated (B)
lincRNAs expressed more than 3-fold (p < 0.01) in the liver of
non-vaccinated (N) and vaccinated mice (V) infected with P. chabaudi
on day 11 p.i. as compared to constitutive expressions on day 0 p.i.
(Nd11 vs. Nd0 and Vd11 vs. Vd0). Numbers in brackets indicate lincRNAs
expressed more than 10-fold.
and to be coordinately regulated as a part of stress-induced
erythropoiesis by Trypanosoma congolense (Thompson et al.,
2010). On the other hand, it is known that the liver is the only
erythropoietic organ in the fetus, and the adult liver of mice is
induced to resume erythropoiesis upon infection with the self-
healing blood-stage malaria of P. yoelii 17X (Abo and Sekikawa,
2002; Halder et al., 2003). De novo clusters of erythroid cells
have been shown in the parenchymal space of the liver. Thus,
our finding, that Cldn13 is massively upregulated in the liver of
vaccinated Balb/c mice, may reflect a local expression of Cldn13
in/around the microenvironment of erythroid clusters, thus
protecting erythroid clusters and erythropoiesis, respectively,
from osmotic perturbations. Local expressions of Cldn13 have
been also described for Sertoli cell tight junctions (Chakraborty
et al., 2014) as well as for neonatal rabbit and rat proximal renal
tubules (Abuazza et al., 2006).
Moreover, even down-regulated genes, for example Lifr, in
the liver may contribute to enhanced liver regeneration in
vaccination-protected mice. The LIF/LIFR system has been
hypothesized to be involved in the expansion and differentiation
of the liver stem cell compartment, which is activated during
liver regeneration (Omori et al., 1996). Moreover, the LIF/LIFR
system shares a common pathway through the common signal
transducer GP130 with the polyfunctional interleukin 6 class
cytokine family, consisting of IL-6, IL-11, OSM (oncostatin
M), CNTF (cilary neurotrophic factor), CT-1 (cardiotrophin-1),
and CLC (cardiotrophin-like cytokine) (Heinrich et al., 2003).
These mutually interacting polyfunctional signaling networks
are rather complex and involve both classic and trans-signaling
mechanisms. For instance, IL-6 classic signaling takes place
only in immune cells and hepatocytes expressing membrane-
bound IL-6 receptor alpha. However, when bound to the soluble
receptor created by ectodomain shedding from the membrane-
bound receptor, IL-6 is then able to communicate by trans-
signaling with all other cells through the ubiquitously expressed
signal transducer GP130. IL-6 trans-signaling has been shown
to play a decisive role in the regulation of liver regeneration
(Scheller et al., 2011; Schmidt-Arras and Rose-John, 2016).
Inhibition of IL-6 trans-signaling protects from P. chabaudi
malaria (Wunderlich et al., 2012).
Moreover, even the differential expression of distinct lincRNA
species with no annotated functions in the liver indicate that liver
regeneration and hepatic erythropoiesis toward the end of the
crisis phase require changes in the expression of diverse lincRNA
species (Quagliata and Terraciano, 2014). Erythropoiesis has
been recently shown to be associated with synthesis of diverse
lncRNAs (Xu et al., 2013), targeted in part by the transcription
factor GATA1 (Alvarez-Dominguez et al., 2014). The gene coding
for GATA1 has been found here to be massively up-regulated by
more than 100-fold in vaccination-protectedmice toward the end
of the crisis phase.
Collectively, our data indicate that protective vaccination
against P. chabaudi malaria leads to changes in the liver,
evidenced as altered gene expression in response to P. chabaudi
malaria toward the end of the crisis phase. These changes in
gene expression support the view that the dramatic decline of P.
chabaudi-infected erythrocytes during crisis is counter-regulated
by hepatic erythropoiesis leading to massive up-regulation of
peripheral reticulocytes, which are not favored as host cells by
P. chabaudi. Concomitantly, there is an accelerated regeneration
of the liver. Both hepatic regeneration and erythropoiesis
contribute to vaccination-induced survival of otherwise lethal
blood-stage malaria of P. chabaudi.
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